D-Chiro-Inositol and Myo-Inositol Induce WAT/BAT Trans-Differentiation in Two Different Human Adipocyte Models (SGBS and LiSa-2)
International Journal of Molecular Sciences · 18.04.2023 · 24 (8) · 7421
DOI: 10.3390/ijms24087421 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.04.2023. Verfasst von Giovanni Monastra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Systems Biology Group Lab, 00161 Rome, Italy. Hauptthemen laut MEDLINE: Inositol, Adipocytes. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: LoLi Pharma, Lo.Li. Pharma srl..
Abstract (Originalsprache)
White adipose tissue/brown adipose tissue trans-differentiation is one of the main study targets for therapies against obesity and metabolic diseases. In recent years, numerous molecules able to induce such trans-differentiation have been identified; however, their effect in obesity therapies has not been as expected. In the present study, we investigated whether myo-inositol and its stereoisomer D-chiro-inositol could be involved in the browning of white adipose tissue. Our preliminary results clearly indicate that both, at 60 μM concentration, induce the upregulation of uncoupling protein 1 mRNA expression, the main brown adipose tissue marker, and increase mitochondrial copy number as well as oxygen consumption ratio. These changes demonstrate an activation of cell metabolism. Therefore, our results show that human differentiated adipocytes (SGBS and LiSa-2), assume the features typical of brown adipose tissue after both treatments. Furthermore, in the cell lines examined, we proved that D-chiro-inositol and myo-Inositol induce an increase in the expression of estrogen receptor mRNAs, suggesting a possible modulation by these isomers. We also found an increase in the mRNA of peroxisome proliferator-activated receptor gamma, a very important target in lipid metabolism and metabolic diseases. Our results open new opportunities for the use of inositols in therapeutic strategies to counteract obesity and its metabolic complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Systems Biology Group Lab, 00161 Rome, Italy.
- Experts Group on Inositols in Basic and Clinical Research (EGOI), 00161 Rome, Italy.
- R&D Department, Lo.Li. Pharma, 00156 Rome, Italy.
- UniCamillus-Saint Camillus International University of Health Sciences, 00131 Rome, Italy.
- Institut Investigació Sanitària Pere Virgili (IISPV), 43003 Tarragona, Spain.
- CIBER de Diabetes y Enfermedades Metaboílicas Asociadas (CIBERDEM)-Instituto de Salud Carlos III, 28029 Madrid, Spain.
ORCID-Profile: Giovanni Monastra, Riccardo Gambioli, Vittorio Unfer
Förderung
- LoLi Pharma
- Lo.Li. Pharma srl.
Zitieren
APA
Monastra, G., Gambioli, R., Unfer, V., Forte, G., Maymo-Masip, E., & Comitato, R. (2023). D-Chiro-Inositol and Myo-Inositol Induce WAT/BAT Trans-Differentiation in Two Different Human Adipocyte Models (SGBS and LiSa-2). International Journal of Molecular Sciences, 24(8), 7421. https://doi.org/10.3390/ijms24087421
Vancouver
Monastra G, Gambioli R, Unfer V, Forte G, Maymo-Masip E, Comitato R. D-Chiro-Inositol and Myo-Inositol Induce WAT/BAT Trans-Differentiation in Two Different Human Adipocyte Models (SGBS and LiSa-2). International Journal of Molecular Sciences. 2023;24(8):7421. doi:10.3390/ijms24087421
BibTeX
@article{Monastra2023,
author = {Monastra, Giovanni and Gambioli, Riccardo and Unfer, Vittorio and Forte, Gianpiero and Maymo-Masip, Elsa and Comitato, Raffaella},
title = {D-Chiro-Inositol and Myo-Inositol Induce WAT/BAT Trans-Differentiation in Two Different Human Adipocyte Models (SGBS and LiSa-2)},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {8},
pages = {7421},
doi = {10.3390/ijms24087421}
}
EUVIMED